- Wide dispersion of subtheme performance in 2021 – Medical Devices (14.3%), Neuroscience (28.7%) versus Telemedicine (down 39.7%) and Gene Sequencing down 20% [1]
- Top monthly contributors across multiple themes - iRhythm up 5.7% (Trackers), Intuitive Surgical up 5.4% (Robotic) [2]
- Ten subthemes, Equal Weight across all 104 current holdings. [3]
- WELL’s returns driven by Medical Device holdings (26.5% weight), Biotech (26.4%), Genome Sequencing (18.6%), Neuroscience (9.8%) & Telemedicine (5.4%). [4]
- Holdings increasingly global – with the US at 70.6%, Japan 8.3%, China 3.1% and Europe 14.1%. [5]
- Digital Healthcare expecting more Big Tech deals – latest Oracle $30bn Cerner electronic data deal. [6]
- US Healthcare digitizing as spending hugely inefficient ~ 20% of GDP. [7]
Past performance is not an indicator for future results and should not be the sole factor of consideration when selecting a product. Please note that all performance figures are showing net data.
Macro Outlook
Increasing prevalence of chronic diseases and the growing awareness re fitness and wellness - driving adoption of innovative wearable medical devices globally. [8]
Telemedicine fast growth expected to rerate beaten down stocks like Teledoc. [9]
North America dominates Telemedicine - double the size of Europe and 6 times larger than Asia-Pacific. [10]
Digital Health estimated at $152.5bn in 2020, projected to reach a revised size of US$456.9bn by 2026 - CAGR of 18.8% annually [11]
Global DNA sequencing market size to hit ~$40bn by 2030, just $8.4bn currently. [12]
Top Subtheme Contributions
|
|
Contribution to Return
|
|
Sub-Themes
|
YTD
|
December
|
|
Telemedicine
|
-39.7%
|
-1.7%
|
|
Genome Sequencing
|
-20.0%
|
-1.2%
|
|
Medical Devices
|
14.3%
|
4.0%
|
|
Neuroscience
|
28.7%
|
3.4%
|
|
Bioinformatics
|
-35.6%
|
-9.4%
|
|
Biological Engineering
|
-5.8%
|
1.4%
|
|
Healthcare Analytics
|
-25.4%
|
-0.9%
|
|
Robotics
|
-56.2%
|
2.9%
|
|
Healthcare Trackers
|
-53.9%
|
-7.1%
|
Past performance is no guarantee of future performance. Please note that all performance figures are showing net data.
Source: INDXX. Data as of 31.12.2021
|
Company Name
|
Sub-Themes
|
December
(Contribution to Return)
|
|
IRHYTHM TECHNOLOGIES INC
|
Healthcare Trackers
|
5.72%
|
|
INTUITIVE SURGICAL INC
|
Robotics |
5.39%
|
|
TABULA RASA HEALTHCARE INC
|
Healthcare Analytics
|
5.32%
|
|
ACADIA PHARMACEUTICALS INC
|
Neuroscience |
2.16%
|
|
NEXTGEN HEALTHCARE INC
|
Telemedicine |
1.85%
|
|
XENON PHARMACEUTICALS INC
|
Neuroscience |
1.70%
|
|
MEIRAGTX HOLDINGS PLC
|
Genome Sequencing
|
1.56%
|
|
1 LIFE HEALTHCARE INC
|
Telemedicine
|
1.29%
|
|
INTRA-CELLULAR THERAPIES INC
|
Biological Engineering |
1.17%
|
|
SAGE THERAPEUTICS INC
|
Neuroscience
|
0.93%
|
|
|
1M
|
3M
|
6M
|
YTD
|
12M
|
2Y
|
3Y
|
SI
|
|
HANS-GINS Indxx Healthcare Megatrend
|
1.22%
|
-7.68%
|
-13.17%
|
-6.77%
|
-6.77%
|
19.19%
|
NA
|
32.43%
|
|
Indxx Global NextGen Healthcare Index (NTR)
|
1.26%
|
-7.71%
|
-13.27%
|
-6.71%
|
-6.71%
|
20.15%
|
51.55%
|
34.27%
|
Past performance for the index is in USD. Past performance is not an indicator for future results and should not be the sole factor of consideration when selecting a product. Investors should read the prospectus of the Issuer (“Prospectus”) before investing and should refer to the section of the Prospectus entitled ‘Risk Factors’ for further details of risks associated with an investment in this product. Source: Bloomberg / HANetf. Data as of 31/12/2021. Please note that all performance figures are showing net data.
Learn more about our Equal Weight ETF
Download the PDF